tiprankstipranks
Trending News
More News >
Mannatech Inc (MTEX)
:MTEX
US Market
Advertisement

Mannatech (MTEX) AI Stock Analysis

Compare
76 Followers

Top Page

MTEX

Mannatech

(NASDAQ:MTEX)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
$9.50
▲(0.53% Upside)
Mannatech's overall stock score reflects significant financial challenges, including declining revenues and negative profitability. Technical analysis provides some positive signals with short-term upward trends, but valuation concerns due to a negative P/E ratio weigh heavily on the score. The absence of earnings call insights and corporate events limits the analysis to financial and technical factors.

Mannatech (MTEX) vs. SPDR S&P 500 ETF (SPY)

Mannatech Business Overview & Revenue Model

Company DescriptionMannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
How the Company Makes MoneyMannatech generates revenue primarily through the sale of its health and wellness products, which include dietary supplements and personal care items. The company's direct selling model allows it to recruit independent associates who earn commissions on product sales, creating a multi-level marketing structure. This model not only drives product sales but also encourages associates to build their own networks, thereby increasing overall sales volume. Additionally, Mannatech may generate income through strategic partnerships and collaborations, enhancing product offerings and expanding market reach. The company also benefits from customer loyalty programs and repeat purchases from existing customers, which contribute to a stable revenue flow.

Mannatech Financial Statement Overview

Summary
Mannatech's financial performance is challenged by declining revenues and negative profitability. The income statement shows a negative net profit margin and operational inefficiencies. The balance sheet indicates manageable leverage but poor return on equity. Cash flow analysis reveals negative operating cash flow, although there is some efficiency in converting income to cash.
Income Statement
45
Neutral
Mannatech's income statement shows a declining revenue trend with a negative revenue growth rate of -2.27% in the TTM period. The gross profit margin remains relatively strong at 75.69%, but the net profit margin is negative at -1.50%, indicating profitability challenges. The EBIT and EBITDA margins are also low, suggesting operational inefficiencies.
Balance Sheet
55
Neutral
The balance sheet reveals a moderate debt-to-equity ratio of 0.87, indicating manageable leverage. However, the return on equity is negative at -22.75%, reflecting poor profitability relative to shareholder equity. The equity ratio is not provided, but the overall financial stability appears to be under pressure due to declining equity.
Cash Flow
40
Negative
Cash flow analysis shows a concerning trend with negative operating cash flow and free cash flow in the TTM period. Although there is a positive free cash flow growth rate of 28.81%, the operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is relatively high at 79.43%, indicating some efficiency in converting income to cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue110.41M117.87M131.96M137.21M159.76M151.41M
Gross Profit82.95M91.46M102.86M102.52M125.61M113.91M
EBITDA1.76M5.55M498.00K3.02M10.61M9.66M
Net Income-1.66M2.49M-2.24M-4.49M9.84M6.26M
Balance Sheet
Total Assets33.92M36.06M41.21M49.13M59.63M65.33M
Cash, Cash Equivalents and Short-Term Investments7.69M11.40M7.73M13.78M24.18M22.21M
Total Debt8.10M6.69M5.71M6.21M1.83M2.83M
Total Liabilities26.97M27.44M30.72M34.95M35.21M39.36M
Stockholders Equity6.95M8.61M10.48M14.18M24.41M25.97M
Cash Flow
Free Cash Flow-3.97M1.96M-3.12M-3.66M10.12M5.08M
Operating Cash Flow-2.89M2.26M-2.37M-2.60M10.77M6.03M
Investing Cash Flow-1.06M-285.00K-747.00K-1.06M-650.00K-947.00K
Financing Cash Flow-1.22M1.96M-1.90M-4.33M-9.29M-9.92M

Mannatech Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.45
Price Trends
50DMA
9.10
Positive
100DMA
8.84
Positive
200DMA
9.48
Positive
Market Momentum
MACD
0.15
Negative
RSI
56.34
Neutral
STOCH
71.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Positive. The current price of 9.45 is above the 20-day moving average (MA) of 9.34, above the 50-day MA of 9.10, and below the 200-day MA of 9.48, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 56.34 is Neutral, neither overbought nor oversold. The STOCH value of 71.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTEX.

Mannatech Risk Analysis

Mannatech disclosed 39 risk factors in its most recent earnings report. Mannatech reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mannatech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$809.87M32.661.62%3.26%-1.34%-73.59%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
$199.51M14.0715.38%-5.47%13.42%
60
Neutral
$464.10M4.3714.55%2.63%-12.10%
50
Neutral
$18.56M-19.54%-9.17%-4.64%
50
Neutral
$13.84M2.2116.79%7.75%-21.61%
46
Neutral
$175.02M-4.90-18.73%-13.14%57.98%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTEX
Mannatech
9.76
1.88
23.86%
NUS
Nu Skin
10.02
2.68
36.51%
EPC
Edgewell Personal Care
17.53
-18.45
-51.28%
SKIN
Beauty Health
1.32
-0.10
-7.04%
EWCZ
European Wax Center
3.67
-2.67
-42.11%
TKLF
Yoshitsu Co. Ltd. Sponsored ADR
2.74
-0.58
-17.47%

Mannatech Corporate Events

Mannatech Inc. Reports Improved Quarterly Earnings Amid Sales Decline
Nov 13, 2025

Mannatech Inc., a Texas-based company, specializes in developing, marketing, and selling nutritional supplements, skin care, anti-aging, and weight-management products through network marketing distribution channels across various global regions. In its latest earnings report for the quarter ending September 30, 2025, Mannatech Inc. reported a net income of $1.9 million, a significant improvement from a net loss of $328,000 in the same quarter of the previous year. However, the company faced a decline in net sales, which fell to $29.2 million from $31.7 million year-over-year. The company’s gross profit also saw a decrease, reflecting the challenges in maintaining sales momentum. Despite the drop in sales, Mannatech managed to reduce its operating expenses, which contributed to the positive net income for the quarter. The company also reported a comprehensive income of $1.06 million, factoring in foreign currency translations. Looking ahead, Mannatech’s management remains focused on strategic initiatives to enhance operational efficiency and expand its market presence, aiming to navigate the competitive landscape and drive future growth.

Private Placements and Financing
Mannatech Extends Loan Repayment to March 2027
Neutral
Sep 12, 2025

On September 9, 2025, Mannatech, Incorporated entered into Loan Extension Agreements with three board members and stockholders, extending the repayment of $3.6 million in loans to March 31, 2027. This extension allows Mannatech additional time to use the funds for general working capital needs, with the option to prepay without penalty.

The most recent analyst rating on (MTEX) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Mannatech stock, see the MTEX Stock Forecast page.

Mannatech Inc. Braces for Profitability Challenges Amid Potential Tariff Changes
Aug 14, 2025

Mannatech Inc. faces significant risks to its profitability and market competitiveness due to potential changes in trade policies, including tariffs. The imposition of new tariffs or increases in existing ones between key trading partners like the United States, Mexico, and China could escalate costs and disrupt supply chains. Despite efforts to mitigate these impacts, such as shifting production locations, the company may struggle with operational complexities and competitive pressures. This could lead to increased prices, potential loss of customers, and adverse effects on revenue and market position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 14, 2025